Who benefits from Phase I studies?
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 1 (3) , 164-165
- https://doi.org/10.1093/oxfordjournals.annonc.a057712
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Pharmacokinetically guided dose escalation in phase I clinical trials. Commentary and proposed guidelinesEuropean Journal of Cancer and Clinical Oncology, 1987
- Quality of life in cancer patients--an hypothesis.Journal of Medical Ethics, 1984
- Informed consent for investigational chemotherapy: patients' and physicians' perceptions.Journal of Clinical Oncology, 1984
- Patient motivation and informed consent in a phase I study of an anticancer agentEuropean Journal of Cancer and Clinical Oncology, 1984